/PRNewswire/ The Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") has today, subject to approval by the Annual General Meeting on 19.
/PRNewswire/ The shareholders in Immunovia AB (publ), Reg. No. 556730-4299, are hereby invited to the Annual General Meeting ("AGM") to be held at The.
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE,
/PRNewswire/ Immunovia will publish its first quarter 2024 results on April 29, 2024 at 8:30 am CET. Analysts, investors and media are invited to a webcast.